Stay updated with breaking news from Stephan Jackman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alzamend Neuro Appoints Dr. Terri Hunter to Its Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace
Full Data Set from Phase I First-in-Human Helped Establish Doses for Phase IIA Multiple Ascending Dose StudyATLANTA--(BUSINESS WIRE)--$ACAD #ACImmune--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodeg...
ATLANTA--(BUSINESS WIRE)--Apr 4, 2022--
FinancialContent fully hosted finance channel
By Michael Dabaie Alzamend Neuro Inc. shares rose 10% to $2.79 Friday after the company said it received positive topline data from a Phase 1 clinical trial for AL001 in dementia related to... | December 17, 2021